The current leadership team at Epirium has a wide range of experience in the finance industry, with a focus on the pharmaceutical and biotech sectors. They have held senior positions at Synthorx Inc, ACADIA Pharmaceuticals Inc., and Cadence Pharmaceuticals (now Mallinckrodt Pharmaceuticals). They also have experience working in assurance services at McGladrey. All members of the team have a business administration degree from Carnegie Mellon University.
View all